##gff-version 3
##sequence-region Q14654 1 390
Q14654	UniProtKB	Chain	1	390	.	.	.	ID=PRO_0000154957;Note=ATP-sensitive inward rectifier potassium channel 11	
Q14654	UniProtKB	Topological domain	1	68	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14654	UniProtKB	Transmembrane	69	93	.	.	.	Note=Helical%3B Name%3DM1;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14654	UniProtKB	Topological domain	94	116	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14654	UniProtKB	Intramembrane	117	128	.	.	.	Note=Helical%3B Pore-forming%3B Name%3DH5;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14654	UniProtKB	Intramembrane	129	135	.	.	.	Note=Pore-forming;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14654	UniProtKB	Topological domain	136	144	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14654	UniProtKB	Transmembrane	145	166	.	.	.	Note=Helical%3B Name%3DM2;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14654	UniProtKB	Topological domain	167	390	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14654	UniProtKB	Motif	130	135	.	.	.	Note=Selectivity filter;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14654	UniProtKB	Site	160	160	.	.	.	Note=Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q14654	UniProtKB	Modified residue	341	341	.	.	.	Note=Phosphothreonine%3B by MAPK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18280666;Dbxref=PMID:18280666	
Q14654	UniProtKB	Modified residue	385	385	.	.	.	Note=Phosphoserine%3B by MAPK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18280666;Dbxref=PMID:18280666	
Q14654	UniProtKB	Alternative sequence	1	87	.	.	.	ID=VSP_045270;Note=In isoform 2. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334;Dbxref=PMID:14702039,PMID:15489334	
Q14654	UniProtKB	Natural variant	10	10	.	.	.	ID=VAR_008659;Note=Rare polymorphism. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9032109;Dbxref=PMID:9032109	
Q14654	UniProtKB	Natural variant	18	18	.	.	.	ID=VAR_055978;Note=A->G;Dbxref=dbSNP:rs41309072	
Q14654	UniProtKB	Natural variant	23	23	.	.	.	ID=VAR_008660;Note=Linked to V-337. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10391210,ECO:0000269|PubMed:15807877,ECO:0000269|PubMed:16429405,ECO:0000269|PubMed:16554811,ECO:0000269|PubMed:8897013,ECO:0000269|PubMed:9032109;Dbxref=dbSNP:rs5219,PMID:10391210,PMID:15807877,PMID:16429405,PMID:16554811,PMID:8897013,PMID:9032109	
Q14654	UniProtKB	Natural variant	34	34	.	.	.	ID=VAR_031329;Note=In HHF2. R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15807877;Dbxref=PMID:15807877	
Q14654	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_026498;Note=In PNDM. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15448107;Dbxref=PMID:15448107	
Q14654	UniProtKB	Natural variant	35	35	.	.	.	ID=VAR_026499;Note=In PNDM. F->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15448106;Dbxref=PMID:15448106	
Q14654	UniProtKB	Natural variant	40	40	.	.	.	ID=VAR_031330;Note=In HHF2. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16357843;Dbxref=PMID:16357843	
Q14654	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_031331;Note=In TNDM3%3B increased spontaneous open probability%3B reduced ATP sensitivity%3B reduced expression at the cell surface of the functional ATP-sensitive form. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15784703;Dbxref=PMID:15784703	
Q14654	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_031332;Note=In PNDM%3B one patient with mild dysmorphic features. H->Y;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16609879,ECO:0000269|PubMed:17213273;Dbxref=PMID:16609879,PMID:17213273	
Q14654	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_026500;Note=In PNDM%3B decreased inhibition by ATP%3B enhanced activation by Mg(2+)%3B increased current%3B one patient with developmental delay. R->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15580558,ECO:0000269|PubMed:16731833;Dbxref=PMID:15580558,PMID:16731833	
Q14654	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_031333;Note=In PNDM%3B decreased inhibition by ATP%3B enhanced activation by Mg(2+)%3B increased current. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16609879,ECO:0000269|PubMed:16731833;Dbxref=PMID:16609879,PMID:16731833	
Q14654	UniProtKB	Natural variant	52	52	.	.	.	ID=VAR_026501;Note=In PNDM%3B with developmental delay and epilepsy%3B produces larger current and more change in ATP sensitivity than mutation associated with mild disease C-201. Q->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15115830,ECO:0000269|PubMed:15583126,ECO:0000269|PubMed:16609879;Dbxref=PMID:15115830,PMID:15583126,PMID:16609879	
Q14654	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_031334;Note=In PNDM%3B with developmental delay and epilepsy. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16609879;Dbxref=PMID:16609879	
Q14654	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_026502;Note=In TNDM3%3B also found in a family member with PNDM%3B reduction in the sensitivity to ATP when compared with wild-type. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15718250;Dbxref=PMID:15718250	
Q14654	UniProtKB	Natural variant	53	53	.	.	.	ID=VAR_026503;Note=In TNDM3%3B also found in a family member with PNDM%3B reduction in the sensitivity to ATP when compared with wild-type. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15718250;Dbxref=PMID:15718250	
Q14654	UniProtKB	Natural variant	55	55	.	.	.	ID=VAR_031335;Note=In HHF2%3B does neither affect channel expression nor channel response to MgADP. F->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16332676,ECO:0000269|PubMed:18596924;Dbxref=PMID:16332676,PMID:18596924	
Q14654	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_026504;Note=In PNDM%3B with developmental delay and epilepsy%3B with neurologic features%3B produces larger current and more change in ATP sensitivity than mutation associated with mild disease C-201%3B decreases ATP sensitivity indirectly by favoring the open conformation of the channel. V->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15115830,ECO:0000269|PubMed:15583126,ECO:0000269|PubMed:16609879;Dbxref=PMID:15115830,PMID:15583126,PMID:16609879	
Q14654	UniProtKB	Natural variant	59	59	.	.	.	ID=VAR_026505;Note=In PNDM%3B four patients with developmental delay and muscle weakness. V->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15115830,ECO:0000269|PubMed:15448106,ECO:0000269|PubMed:15448107,ECO:0000269|PubMed:15580558,ECO:0000269|PubMed:16609879;Dbxref=PMID:15115830,PMID:15448106,PMID:15448107,PMID:15580558,PMID:16609879	
Q14654	UniProtKB	Natural variant	60	60	.	.	.	ID=VAR_073681;Note=In PNDM%3B found in a patient who also carries L-64 in cis%3B thought to be the pathogenic mutation in this double allele%3B displays gain of function%3B increases the intrinsic channel open probability and decreases sensitivity toward ATP inhibition%3B variant L-64 associated in cis is thought to ameliorate the effect of the Y-60 mutation on the channel ATP sensitivity. F->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20022885;Dbxref=PMID:20022885	
Q14654	UniProtKB	Natural variant	64	64	.	.	.	ID=VAR_073682;Note=In PNDM%3B found in a patient who also carries Y-60 in cis%3B unknown pathological significance%3B only subtle effects%2C if any%2C on channel ATP sensitivity%3B thought to attenuate the deleterious effect of the Y-60 mutation associated in cis on the channel ATP sensitivity. V->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20022885,ECO:0000269|PubMed:28842488;Dbxref=PMID:20022885,PMID:28842488	
Q14654	UniProtKB	Natural variant	67	67	.	.	.	ID=VAR_026506;Note=In HHF2. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12364426;Dbxref=PMID:12364426	
Q14654	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_026507;Note=In HHF2. W->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10204114;Dbxref=PMID:10204114	
Q14654	UniProtKB	Natural variant	101	101	.	.	.	ID=VAR_031336;Note=In HHF2. A->D;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15562009,ECO:0000269|PubMed:16357843;Dbxref=PMID:15562009,PMID:16357843	
Q14654	UniProtKB	Natural variant	116	116	.	.	.	ID=VAR_031337;Note=In HHF2. S->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16357843;Dbxref=PMID:16357843	
Q14654	UniProtKB	Natural variant	134	134	.	.	.	ID=VAR_031338;Note=In HHF2. G->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15562009;Dbxref=PMID:15562009	
Q14654	UniProtKB	Natural variant	136	136	.	.	.	ID=VAR_031339;Note=In HHF2. R->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15562009,ECO:0000269|PubMed:16357843;Dbxref=PMID:15562009,PMID:16357843	
Q14654	UniProtKB	Natural variant	147	147	.	.	.	ID=VAR_001557;Note=In HHF2. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:7847376,ECO:0000269|PubMed:8923010;Dbxref=dbSNP:rs28936678,PMID:7847376,PMID:8923010	
Q14654	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_031340;Note=I->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15807877,ECO:0000269|PubMed:7502040;Dbxref=PMID:15807877,PMID:7502040	
Q14654	UniProtKB	Natural variant	156	156	.	.	.	ID=VAR_073683;Note=In HHF2. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18596924;Dbxref=PMID:18596924	
Q14654	UniProtKB	Natural variant	164	164	.	.	.	ID=VAR_031341;Note=In PNDM. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16609879,ECO:0000269|PubMed:17213273;Dbxref=PMID:16609879,PMID:17213273	
Q14654	UniProtKB	Natural variant	166	166	.	.	.	ID=VAR_031342;Note=In PNDM%3B individual also diagnosed with West syndrome. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16609879;Dbxref=PMID:16609879	
Q14654	UniProtKB	Natural variant	167	167	.	.	.	ID=VAR_073684;Note=In PNDM%3B has severely impaired sensitivity to ATP and markedly increases open channel probability. I->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17652641;Dbxref=PMID:17652641	
Q14654	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_026508;Note=In PNDM. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15580558;Dbxref=PMID:15580558	
Q14654	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_026509;Note=In PNDM. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15580558;Dbxref=PMID:15580558	
Q14654	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_031343;Note=In PNDM. K->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16609879;Dbxref=PMID:16609879	
Q14654	UniProtKB	Natural variant	182	182	.	.	.	ID=VAR_026510;Note=In TNDM3%3B reduction in the sensitivity to ATP when compared with wild-type. I->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15718250;Dbxref=PMID:15718250	
Q14654	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_014929;Note=R->H;Dbxref=dbSNP:rs5217	
Q14654	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_026511;Note=In PNDM%3B two individuals with developmental delay%3B produces smaller current and less change in ATP sensitivity than mutations associated with severe disease R-52 and G-59. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15115830,ECO:0000269|PubMed:15292329,ECO:0000269|PubMed:15448107,ECO:0000269|PubMed:15580558,ECO:0000269|PubMed:15583126,ECO:0000269|PubMed:16609879;Dbxref=PMID:15115830,PMID:15292329,PMID:15448107,PMID:15580558,PMID:15583126,PMID:16609879	
Q14654	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_026512;Note=In PNDM%3B ability of ATP to block mutant channels greatly reduced. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15115830,ECO:0000269|PubMed:15448106,ECO:0000269|PubMed:15448107,ECO:0000269|PubMed:16609879,ECO:0000269|PubMed:17213273;Dbxref=PMID:15115830,PMID:15448106,PMID:15448107,PMID:16609879,PMID:17213273	
Q14654	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_031344;Note=In PNDM. R->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16609879;Dbxref=PMID:16609879	
Q14654	UniProtKB	Natural variant	204	204	.	.	.	ID=VAR_073685;Note=In HHF2. D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18596924;Dbxref=PMID:18596924	
Q14654	UniProtKB	Natural variant	227	227	.	.	.	ID=VAR_073686;Note=In MODY13. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22701567;Dbxref=PMID:22701567	
Q14654	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_026513;Note=In HHF2%3B impairs trafficking of the mutant channel. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15579781;Dbxref=PMID:15579781	
Q14654	UniProtKB	Natural variant	259	259	.	.	.	ID=VAR_031345;Note=In HHF2%3B impairs trafficking and abolishes channel function. H->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15998776;Dbxref=PMID:15998776	
Q14654	UniProtKB	Natural variant	266	266	.	.	.	ID=VAR_031346;Note=In HHF2. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15562009;Dbxref=PMID:15562009	
Q14654	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_008661;Note=L->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:8897013,ECO:0000269|PubMed:9032109;Dbxref=dbSNP:rs1800467,PMID:8897013,PMID:9032109	
Q14654	UniProtKB	Natural variant	282	282	.	.	.	ID=VAR_073687;Note=In HHF2%3B prevents the ER export and surface expression of the channel. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19357197;Dbxref=PMID:19357197	
Q14654	UniProtKB	Natural variant	296	296	.	.	.	ID=VAR_026514;Note=In PNDM%3B with developmental delay and epilepsy. I->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15115830,ECO:0000269|PubMed:16609879;Dbxref=PMID:15115830,PMID:16609879	
Q14654	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_031347;Note=In HHF2. R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15562009,ECO:0000269|PubMed:16357843;Dbxref=PMID:15562009,PMID:16357843	
Q14654	UniProtKB	Natural variant	322	322	.	.	.	ID=VAR_026515;Note=In PNDM. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15448107;Dbxref=PMID:15448107	
Q14654	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_026516;Note=In PNDM. Y->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15448106,ECO:0000269|PubMed:15448107;Dbxref=PMID:15448106,PMID:15448107	
Q14654	UniProtKB	Natural variant	330	330	.	.	.	ID=VAR_031348;Note=In PNDM. Y->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16609879;Dbxref=PMID:16609879	
Q14654	UniProtKB	Natural variant	333	333	.	.	.	ID=VAR_026517;Note=In PNDM%3B alters gating characteristics%2C decreases sensitivity to inhibition by ATP and increases intrinsic open probability. F->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15448106,ECO:0000269|PubMed:17855752;Dbxref=PMID:15448106,PMID:17855752	
Q14654	UniProtKB	Natural variant	337	337	.	.	.	ID=VAR_008662;Note=Linked to K-23. I->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10391210,ECO:0000269|PubMed:15807877,ECO:0000269|PubMed:16429405,ECO:0000269|PubMed:16554811,ECO:0000269|PubMed:8897013,ECO:0000269|PubMed:9032109;Dbxref=dbSNP:rs5215,PMID:10391210,PMID:15807877,PMID:16429405,PMID:16554811,PMID:8897013,PMID:9032109	
Q14654	UniProtKB	Natural variant	355	355	.	.	.	ID=VAR_008663;Note=In NIDDM%3B Afro-Caribbean. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8897013;Dbxref=PMID:8897013	
Q14654	UniProtKB	Natural variant	380	380	.	.	.	ID=VAR_008664;Note=In NIDDM. P->PKP	
Q14654	UniProtKB	Natural variant	385	385	.	.	.	ID=VAR_008665;Note=S->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:8897013;Dbxref=dbSNP:rs41282930,PMID:8897013	
Q14654	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Displays gain of function%3B increased open state stability%2C reduced ATP sensitivity and increased channel activity%3B almost completely abolishes high affinity sensitivity to glibenclamide%2C an inhibitor of ATP-sensitive potassium channels. V->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28842488;Dbxref=PMID:28842488	
Q14654	UniProtKB	Sequence conflict	370	370	.	.	.	Note=K->E;Ontology_term=ECO:0000305;evidence=ECO:0000305	
